Sfoglia per Rivista HAEMATOLOGICA
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
2003-01-01 Mauro, Fr; Zinzani, P; Zaja, F; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, R; Baccarani, M; Tura, S; Mandelli, F.
Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients.
2002-01-01 Mauro, Fr; Foa, R; Meloni, G; Gentile, M; Giammartini, E; Giannarelli, D; De Propris, Ms; Rapanotti, Mc; de Fabritiis, P; Mandelli, F.
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial
2019-01-01 Bringhen, S; D'Agostino, M; Paris, L; Ballanti, S; Pescosta, N; Spada, S; Pezzatti, S; Grasso, M; Rota-Scalabrini, D; De Rosa, L; Pavone, V; Gazzera, G; Aquino, S; Poggiu, M; Santoro, A; Gentile, M; Baldini, L; Petrucci, Mt; Tosi, P; Marasca, R; Cellini, C; Palumbo, A; Falco, P; Hájek, R; Boccadoro, M; Larocca, A.
Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages.
2009-01-01 Gentile, M; Cutrona, G; Neri, A; Molica, S; Ferrarini, M; Morabito, F.
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
2002-01-01 Mauro, Fr; Gentile, M; Mancini, F; Giannarelli, D; Guarini, A; De Propriis, Ms; Cerretti, R; Foa, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. | 1-gen-2003 | Mauro, Fr; Zinzani, P; Zaja, F; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, R; Baccarani, M; Tura, S; Mandelli, F. | |
| Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients. | 1-gen-2002 | Mauro, Fr; Foa, R; Meloni, G; Gentile, M; Giammartini, E; Giannarelli, D; De Propris, Ms; Rapanotti, Mc; de Fabritiis, P; Mandelli, F. | |
| Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial | 1-gen-2019 | Bringhen, S; D'Agostino, M; Paris, L; Ballanti, S; Pescosta, N; Spada, S; Pezzatti, S; Grasso, M; Rota-Scalabrini, D; De Rosa, L; Pavone, V; Gazzera, G; Aquino, S; Poggiu, M; Santoro, A; Gentile, M; Baldini, L; Petrucci, Mt; Tosi, P; Marasca, R; Cellini, C; Palumbo, A; Falco, P; Hájek, R; Boccadoro, M; Larocca, A. | |
| Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages. | 1-gen-2009 | Gentile, M; Cutrona, G; Neri, A; Molica, S; Ferrarini, M; Morabito, F. | |
| Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone. | 1-gen-2002 | Mauro, Fr; Gentile, M; Mancini, F; Giannarelli, D; Guarini, A; De Propriis, Ms; Cerretti, R; Foa, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile